Investors see more opportunities in the growth mezzanine space as China’s economy slows, but deal structuring is a challenge due to the need for onshore and offshore components
China Everbright (CEL) started providing structured solutions six years ago and they have become the firm's core strategy. These hybrid debt-plus-equity instruments offer a flexibility largely unavailable...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.